Opaleye Management Inc.

13F Holdings History for Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)

Symbol: TARA on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 1.73M shares
Security Ownership: 4.71%

Shares, Excluding Options vs Price

Value, Excluding Options

Opaleye Management, Inc. ownership in Protara Therapeutics, Inc. Common Stock, par value $0.001 per share (TARA)

2025-04-28 - Opaleye Management, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.73M shares of Protara Therapeutics, Inc. Common Stock, par value $0.001 per share (TARA). This represents 4.71% percent ownership of the company. In their previous filing dated 2025-02-14, Opaleye Management Inc. had reported owning 1.83M shares, indicating a decrease of -5.21% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Opaleye Management, Inc.	4.71%	-12.2%	$6.75M	1.73M	-95,000	-5.21%	$3.90	13G/A	3/31/2025	28 Apr 2025 16:05:08
Opaleye Management, Inc.	5.32%		$7.12M	1.83M			$3.90	13G/A	12/31/2024	14 Feb 2025 06:31:40

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.52%	-0.54%	$2.59M	855K	-875,000	-50.6%	$3.03	Q2 2025
3/31/2025	1.64%	-0.09%	$7.37M	1.73M	-95,000		$4.26	Q1 2025
12/31/2024	1.69%	+0.13%	$9.64M	1.83M	+143,846	+8.56%	$5.28	Q4 2024
9/30/2024	0.51%	-0.19%	$3.08M	1.68M	-623,108	-27%	$1.83	Q3 2024
6/30/2024	1.21%	-0.2%	$5.3M	2.3M	-388,332	-14.4%	$2.30	Q2 2024
3/31/2024	2.35%		$10.8M	2.69M			$4.01	Q1 2024
12/31/2023	1.34%		$5.05M	2.69M			$1.88	Q4 2023
9/30/2023	1.46%		$4.5M	2.69M			$1.67	Q3 2023
6/30/2023	1.54%		$6.44M	2.69M			$2.39	Q2 2023
3/31/2023	2.42%		$8.08M	2.69M			$3.00	Q1 2023
12/31/2022	2.51%	-0.01%	$7.22M	2.69M	-15,473	-0.57%	$2.68	Q4 2022
9/30/2022	3.3%	+0.03%	$7.99M	2.71M	+23,900	+0.89%	$2.95	Q3 2022
6/30/2022	4%	+0.02%	$8.89M	2.68M	+10,136	+0.38%	$3.31	Q2 2022
3/31/2022	4.24%	+0.04%	$13.7M	2.67M	+24,031	+0.91%	$5.11	Q1 2022
12/31/2021	3.82%	+0.13%	$18M	2.65M	+91,528	+3.58%	$6.79	Q4 2021
9/30/2021	3.31%		$17.7M	2.56M			$6.92	Q3 2021
6/30/2021	4.14%		$24.9M	2.56M			$9.74	Q2 2021
3/31/2021	5.92%		$40.3M	2.56M			$15.74	Q1 2021
12/31/2020	8.09%		$61.9M	2.56M			$24.21	Q4 2020
9/30/2020	8.42%	+1.15%	$43.1M	2.56M	+350,000	+15.8%	$16.83	Q3 2020
6/30/2020	13.1%	+13.1%	$64.8M	2.21M	+2,208,472	NEW	$29.32	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.